10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Immune malfunction in the GPR39 zinc receptor of knockout mice: Its relationship to depressive disorder.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Depression is a serious psychiatric disorder affecting not only the monaminergic, glutamatergic, and GABAergic neurosystems, but also the immune system. Patients suffering from depression show disturbance in the immune parameters as well as increased susceptibility to infections. Zinc is well known as an anti-inflammatory agent, and its link with depression has been proved, zinc deficiency causing depression- and anxiety-like behavior with immune malfunction. It has been discovered that trace-element zinc acts as a neurotransmitter in the central nervous system via zinc receptor GPR39. In this study we investigated whether GPR39 knockout would cause depressive-like behavior as measured by the forced swim test, and whether these changes would coexist with immune malfunction. In GPR39 knockout mice versus a wild-type control we found: i) depressive-like behavior; ii) significantly reduced thymus weight; (iii) reduced cell viability of splenocytes; iv) reduced proliferative response of splenocytes; and v) increased IL-6 production of splenocytes after ConA stimulation and decreased IL-1b and IL-6 release after LPS stimulation. The results indicate depressive-like behavior in GPR39 KO animals with an immune response similar to that observed in depressive disorder. Here for the first time we show immunological changes under GPR39-deficient conditions.

          Related collections

          Author and article information

          Journal
          J. Neuroimmunol.
          Journal of neuroimmunology
          Elsevier BV
          1872-8421
          0165-5728
          Feb 15 2016
          : 291
          Affiliations
          [1 ] Department of Pharmacobiology, Jagiellonian University Medical College, Medyczna 9, PL 30-688 Kraków, Poland. Electronic address: katarzyna.mlyniec@uj.edu.pl.
          [2 ] Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, PeL 31-343 Kraków, Poland.
          [3 ] Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, PeL 31-343 Kraków, Poland; Department of Biochemical Toxicology, Jagiellonian University Medical College, Medyczna 9, PL 30-688 Kraków, Poland.
          [4 ] 1st Department of Psychiatry, Medical University of Warsaw, Nowowiejski Hospital, Nowowiejska 27, PL 02-156 Warszawa, Poland.
          [5 ] Department of Pharmacobiology, Jagiellonian University Medical College, Medyczna 9, PL 30-688 Kraków, Poland.
          [6 ] Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.
          [7 ] Department of Pharmacobiology, Jagiellonian University Medical College, Medyczna 9, PL 30-688 Kraków, Poland; Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, PeL 31-343 Kraków, Poland.
          Article
          S0165-5728(15)30094-1
          10.1016/j.jneuroim.2015.12.001
          26857489
          b3c2c8e7-5073-47be-8eb1-145e7b0055da
          History

          Depression,GPR39,Immune system,Proliferation,Zinc
          Depression, GPR39, Immune system, Proliferation, Zinc

          Comments

          Comment on this article